COMMUNIQUÉS West-GlobeNewswire

IntelGenx Reports Fourth Quarter and Full-Year 2018 Financial Results
22/03/2019
SAINT LAURENT, Quebec, March 22, 2019 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX-V:IGX)(OTCQX:IGXT) (the "Company" or "IntelGenx") today reported financial results for the fourth quarter and twelve-month [...]
Dermira Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
22/03/2019
MENLO PARK, Calif., March 22, 2019 (GLOBE NEWSWIRE) -- Dermira, Inc. (NASDAQ: DERM), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated, new therapies [...]
BioSyent Announces Notice of Deficiency for Cardiovascular Products
22/03/2019
TORONTO, March 22, 2019 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) announces that it has been informed by Health Canada that the Company will receive a Notice of Deficiency (“NOD”) [...]
Junior Welterweight Blair "The Flair" Cobbs Sports Diamond CBD Logo in Championship-Winning Fight
22/03/2019
CBD company extends its presence both inside and out of the ring FT. LAUDERDALE, Fla., March 22, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Diamond CBD Inc., a wholly owned subsidiary of PotNetwork Holdings, Inc. (OTC [...]
Tecan to vertically integrate supplier of key parts
22/03/2019
Männedorf, Switzerland, March 22, 2019 – The Tecan Group (SIX Swiss Exchange: TECN) announced today that it has signed agreements to acquire a long-term supplier to vertically integrate the manufacturing of critical [...]
Recro Pharma Receives Complete Response Letter from the FDA for Intravenous Meloxicam
22/03/2019
Management to Host Conference Call and Webcast Today at 4:30 p.m. ET MALVERN, Pa., March 22, 2019 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq:REPH), a revenue generating specialty pharmaceutical company focused on [...]
Sanofi: FDA issues Complete Response Letter for Zynquista(TM) (sotagliflozin)
22/03/2019
FDA issues Complete Response Letter for Zynquista(TM) (sotagliflozin) PARIS and THE WOODLANDS, TX - March 22, 2019 - The U.S. Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) regarding the New [...]
Sanofi : La FDA publie une lettre de réponse complète au sujet de Zynquista(TM) (sotagliflozine)
22/03/2019
La FDA publie une lettre de réponse complète au sujet de Zynquista(TM) (sotagliflozine) Paris et The Woodlands (Texas) - Le 22 mars 2019 - La Food and Drug Administration (FDA) des États-Unis a publié une lettre de [...]
Lexicon Pharmaceuticals to Host Conference Call and Webcast Today, March 22, 2019 to Provide a Regulatory Update on Sotagliflozin in Type 1 Diabetes
22/03/2019
THE WOODLANDS, Texas, March 22, 2019 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that management will conduct a conference call and live webcast today, Friday, March 22, 2019, at 2: [...]
FDA Issues Complete Response Letter for Zynquista™ (sotagliflozin)
22/03/2019
PARIS and THE WOODLANDS, Texas, March 22, 2019 (GLOBE NEWSWIRE) -- The U.S. Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) regarding the New Drug Application for investigational Zynquista™ ( [...]
IBA SA: transparency notification
22/03/2019
IBA – TRANSPARENCY NOTIFICATION Louvain-la-Neuve, Belgium, March 22, 2019, 17.35 - IBA (Ion Beam Applications SA), the world’s leading provider of proton therapy solutions for the treatment of cancer, announces that it [...]
IBA SA - Notification de transparence
22/03/2019
IBA - NOTIFICATION DE TRANSPARENCE Louvain-la-Neuve, Belgique, 22 mars 2019, 17.35 – IBA (Ion Beam Applications SA), le premier fournisseur mondial de solutions de protonthérapie pour le traitement du cancer, annonce [...]
Correction: Removal of the MAR plate in the release: The observation status of Oncology Venture is removed
22/03/2019
Press release Hørsholm, Denmark and Cambridge, MA, US, March 22, 2019 – Oncology Venture A/S announced today that the observation status for the share on Nasdaq First North has been removed. The decision was taken by [...]
2018 Annual Report and Accounts and Notice of AGM
22/03/2019
LONDON, March 22, 2019 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (Nasdaq:VRNA) (“Verona Pharma”), a clinical stage biopharmaceutical company focused on developing and commercializing innovative therapies for [...]
Correction to Financial Statement Bulletin of BBS-Bioactive Bone Substitutes Plc, published 22th March 2019 at 9:00 CET
22/03/2019
BBS-Bioactive Bone Substitutes Plc Correction to Financial Statement Bulletin of BBS-Bioactive Bone Substitutes Plc, published 22th March 2019 at 9:00 CET. Unfortunately, some incorrect dates and periods were in the [...]
Assure Holdings Announces Estimated Impact from Fourth Quarter 2018 Increase in Bad Debt Expense
22/03/2019
DENVER, March 22, 2019 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “ Company ” or “ Assure ”) (TSXV: IOM; OTCQB: ARHH), a provider of intraoperative neuromonitoring services, announced today that it was increasing [...]
The observation status of Oncology Venture is removed
22/03/2019
Press release Hørsholm, Denmark and Cambridge, MA, US, March 22, 2019 – Oncology Venture A/S announced today that the observation status for the share on Nasdaq First North has been removed. The decision was taken by [...]
Providence Cancer Institute to Present Findings on GR-MD-02 at the 2019 Keystone Symposia on Molecular and Cellular Biology
22/03/2019
NORCROSS, Ga., March 22, 2019 (GLOBE NEWSWIRE) -- Providence Cancer Institute and Galectin Therapeutics Inc. (NASDAQ: GALT) , the leading developer of therapeutics that target galectin proteins, announced today a [...]
resTORbio, Inc. Announces Closing Public Offering of Common Stock
22/03/2019
BOSTON, March 22, 2019 (GLOBE NEWSWIRE) -- resTORbio, Inc. (“resTORbio” or the “Company”) (Nasdaq:TORC), a clinical-stage biopharmaceutical company developing innovative medicines that target the biology of aging to [...]

Pages